| Lastest Insider Transactions Of BridgeBio Pharma, Inc. ( BBIO ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2026-05-16 | Option Exercise | 71,215 | 0.00 | 0 | 2026-05-19 16:27:55 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2026-05-15 | Sell | 10,000 | 67.15 | 671,456 | 2026-05-19 16:25:29 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2026-05-15 | Option Exercise | 10,000 | 16.75 | 167,500 | 2026-05-19 16:25:29 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2026-05-07 | Sell | 80,000 | 67.40 | 5,392,244 | 2026-05-11 17:15:29 |
| BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | 2026-04-30 | Sell | 2,000 | 71.58 | 143,160 | 2026-05-04 16:22:25 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2026-04-09 | Sell | 80,000 | 74.61 | 5,968,780 | 2026-04-13 18:06:06 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2026-03-12 | Sell | 80,000 | 68.76 | 5,501,068 | 2026-03-16 18:05:14 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2026-03-10 | Sell | 8,671 | 72.00 | 624,312 | 2026-03-12 16:15:36 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2026-03-10 | Option Exercise | 8,671 | 27.36 | 237,239 | 2026-03-12 16:15:36 |
| BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Directior | 2026-03-04 | Sell | 64,921 | 64.87 | 4,211,302 | 2026-03-06 16:57:57 |
| BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Directior | 2026-03-04 | Option Exercise | 64,921 | 8.45 | 548,582 | 2026-03-06 16:57:57 |
| BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | 2026-02-26 | Sell | 2,000 | 66.00 | 132,000 | 2026-02-27 16:11:15 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2026-02-19 | Sell | 28,053 | 71.39 | 2,002,718 | 2026-02-23 16:32:04 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2026-02-16 | Option Exercise | 64,698 | 0.00 | 0 | 2026-02-18 18:41:47 |
| BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | 2026-02-16 | Sell | 510 | 74.31 | 37,898 | 2026-02-18 18:39:24 |
| BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | 2026-02-16 | Sell | 13,600 | 74.72 | 1,016,147 | 2026-02-18 18:36:26 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2026-02-17 | Sell | 10,000 | 75.46 | 754,557 | 2026-02-18 18:34:13 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2026-02-17 | Option Exercise | 10,000 | 16.75 | 167,500 | 2026-02-18 18:34:13 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2026-02-10 | Sell | 80,000 | 71.86 | 5,748,666 | 2026-02-12 16:39:55 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2026-01-08 | Sell | 80,000 | 75.54 | 6,043,168 | 2026-01-12 21:01:29 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-12-12 | Sell | 30,011 | 74.64 | 2,239,902 | 2025-12-16 18:27:18 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-12-12 | Option Exercise | 60,975 | 0.00 | 0 | 2025-12-16 18:27:18 |
| BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | 2025-12-08 | Sell | 2,000 | 74.26 | 148,520 | 2025-12-10 07:53:52 |
| BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | 2025-12-08 | Sell | 2,000 | 74.26 | 148,520 | 2025-12-10 07:53:52 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-12-04 | Sell | 80,000 | 73.86 | 5,908,476 | 2025-12-08 17:54:11 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-11-20 | Sell | 26,156 | 65.84 | 1,722,224 | 2025-11-24 18:46:42 |
| BBIO | BridgeBio Pharma, Inc. | Lo Andrew | Directior | 2025-11-17 | Sell | 95,599 | 66.11 | 6,319,663 | 2025-11-19 17:08:19 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2025-11-17 | Sell | 10,000 | 66.65 | 666,465 | 2025-11-19 17:06:52 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2025-11-17 | Option Exercise | 10,000 | 16.75 | 167,500 | 2025-11-19 17:06:52 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-11-16 | Option Exercise | 64,697 | 0.00 | 0 | 2025-11-18 19:31:31 |
| BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | 2025-11-16 | Sell | 16,934 | 66.46 | 1,125,404 | 2025-11-18 19:28:59 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2025-11-12 | Sell | 25,484 | 66.07 | 1,683,728 | 2025-11-14 16:50:41 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2025-11-12 | Option Exercise | 25,484 | 48.45 | 1,234,700 | 2025-11-14 16:50:41 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-11-06 | Sell | 80,000 | 62.29 | 4,983,111 | 2025-11-10 17:33:56 |
| BBIO | BridgeBio Pharma, Inc. | DANIELS RONALD J | Directior | 2025-11-06 | Sell | 61,031 | 63.72 | 3,888,999 | 2025-11-07 18:03:37 |
| BBIO | BridgeBio Pharma, Inc. | DANIELS RONALD J | Directior | 2025-11-06 | Option Exercise | 61,031 | 34.65 | 2,114,724 | 2025-11-07 18:03:37 |
| BBIO | BridgeBio Pharma, Inc. | MCCORMICK FRANK | Directior | 2025-10-29 | Sell | 198,359 | 66.58 | 13,206,528 | 2025-10-31 16:38:45 |
| BBIO | BridgeBio Pharma, Inc. | MCCORMICK FRANK | Directior | 2025-10-27 | Sell | 1,641 | 65.00 | 106,665 | 2025-10-29 17:10:31 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-10-08 | Sell | 80,000 | 54.79 | 4,383,442 | 2025-10-10 17:40:12 |
| BBIO | BridgeBio Pharma, Inc. | MCCORMICK FRANK | Directior | 2025-09-05 | Sell | 74,000 | 53.16 | 3,933,544 | 2025-09-08 18:06:31 |
| BBIO | BridgeBio Pharma, Inc. | MCCORMICK FRANK | Directior | 2025-09-05 | Option Exercise | 74,000 | 11.92 | 882,080 | 2025-09-08 18:06:31 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-09-04 | Sell | 80,000 | 52.20 | 4,175,835 | 2025-09-08 18:05:34 |
| BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | 2025-08-21 | Sell | 42,237 | 49.48 | 2,090,081 | 2025-08-22 16:58:52 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-08-20 | Sell | 26,156 | 48.82 | 1,276,927 | 2025-08-22 16:46:46 |
| BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | 2025-08-16 | Sell | 17,353 | 50.23 | 871,722 | 2025-08-19 19:40:20 |
| BBIO | BridgeBio Pharma, Inc. | Trimarchi Thomas | President and CFO | 2025-08-16 | Sell | 17,353 | 50.23 | 871,722 | 2025-08-19 19:40:20 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-08-16 | Option Exercise | 64,697 | 0.00 | 0 | 2025-08-19 19:38:18 |
| BBIO | BridgeBio Pharma, Inc. | HOMCY CHARLES J | Directior | 2025-08-08 | Sell | 300,000 | 46.37 | 13,912,443 | 2025-08-12 19:06:17 |
| BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | 2025-08-07 | Sell | 1,000 | 45.44 | 45,440 | 2025-08-11 18:29:56 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-08-07 | Sell | 80,000 | 45.84 | 3,666,949 | 2025-08-11 18:12:42 |
| BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Directior | 2025-08-05 | Sell | 17,167 | 49.00 | 841,183 | 2025-08-07 16:50:17 |
| BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Directior | 2025-08-05 | Option Exercise | 17,167 | 16.75 | 287,547 | 2025-08-07 16:50:17 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-07-01 | Sell | 80,000 | 42.63 | 3,410,451 | 2025-07-03 16:30:19 |
| BBIO | BridgeBio Pharma, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | 2025-06-27 | Sell | 3,500,000 | 44.00 | 154,000,000 | 2025-07-01 19:48:36 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2025-06-26 | Sell | 4,707 | 44.05 | 207,327 | 2025-06-30 17:51:41 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2021-12-29 | Buy | 1,752 | 14.24 | 24,948 | 2025-06-30 17:49:25 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2021-12-28 | Buy | 2,338 | 12.84 | 30,028 | 2025-06-30 17:46:18 |
| BBIO | BridgeBio Pharma, Inc. | MCCORMICK FRANK | Directior | 2025-06-24 | Sell | 100,000 | 44.23 | 4,422,800 | 2025-06-26 17:08:05 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2025-06-10 | Sell | 4,292 | 40.00 | 171,680 | 2025-06-11 17:00:04 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2025-06-10 | Option Exercise | 4,292 | 16.75 | 71,891 | 2025-06-11 17:00:04 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-05-16 | Sell | 101,156 | 33.38 | 3,376,741 | 2025-05-20 18:06:46 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-05-16 | Option Exercise | 64,696 | 0.00 | 0 | 2025-05-20 18:06:46 |
| BBIO | BridgeBio Pharma, Inc. | KKR Genetic Disorder L.P. | 10% Owner | 2025-05-12 | Sell | 6,000,000 | 34.20 | 205,200,000 | 2025-05-14 17:24:23 |
| BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | Chief Accounting Officer | 2025-05-02 | Sell | 1,026 | 38.51 | 39,509 | 2025-05-06 16:45:19 |
| BBIO | BridgeBio Pharma, Inc. | Lo Andrew | Directior | 2025-05-02 | Sell | 100,000 | 38.50 | 3,849,900 | 2025-05-06 16:42:23 |
| BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Directior | 2025-04-14 | Sell | 10,000 | 35.00 | 350,000 | 2025-04-16 17:39:06 |
| BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Directior | 2025-04-14 | Option Exercise | 10,000 | 8.45 | 84,500 | 2025-04-16 17:39:06 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-03-25 | Sell | 75,000 | 36.87 | 2,764,943 | 2025-03-27 16:54:21 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2025-03-06 | Sell | 12,875 | 32.58 | 419,500 | 2025-03-10 16:43:50 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2025-03-06 | Option Exercise | 12,875 | 16.75 | 215,656 | 2025-03-10 16:43:50 |
| BBIO | BridgeBio Pharma, Inc. | KKR Genetic Disorder L.P. | 10% Owner | 2025-03-05 | Sell | 6,000,000 | 32.96 | 197,760,000 | 2025-03-07 18:09:03 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO and Treasurer | 2025-02-25 | Sell | 8,500 | 33.19 | 282,115 | 2025-02-27 17:36:47 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | CFO and Treasurer | 2025-02-25 | Option Exercise | 8,500 | 17.00 | 144,500 | 2025-02-27 17:36:47 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-02-25 | Sell | 75,000 | 33.57 | 2,517,971 | 2025-02-27 17:12:40 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2025-02-16 | Sell | 4,148 | 36.16 | 149,973 | 2025-02-19 20:50:47 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2025-02-16 | Option Exercise | 25,798 | 0.00 | 0 | 2025-02-19 20:50:47 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-02-16 | Sell | 31,543 | 36.14 | 1,140,024 | 2025-02-19 20:48:57 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-02-16 | Option Exercise | 55,539 | 0.00 | 0 | 2025-02-19 20:48:57 |
| BBIO | BridgeBio Pharma, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | 2025-01-31 | Sell | 3,065,616 | 34.90 | 106,990,000 | 2025-01-31 19:18:25 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2025-01-28 | Sell | 68,000 | 36.29 | 2,467,761 | 2025-01-30 18:31:19 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2025-01-28 | Option Exercise | 68,000 | 17.00 | 1,156,000 | 2025-01-30 18:31:19 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2025-01-28 | Sell | 600,000 | 36.31 | 21,788,650 | 2025-01-30 18:29:15 |
| BBIO | BridgeBio Pharma, Inc. | Satvat Ali J. | Directior | 2024-12-30 | Option Exercise | 159,404 | 16.22 | 2,585,134 | 2024-12-31 17:52:25 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2024-11-19 | Sell | 27,389 | 22.41 | 613,826 | 2024-11-20 20:00:38 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2024-11-19 | Sell | 4,156 | 22.41 | 93,137 | 2024-11-20 19:57:37 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2024-11-16 | Option Exercise | 55,537 | 0.00 | 0 | 2024-11-19 18:15:42 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2024-11-16 | Option Exercise | 25,799 | 0.00 | 0 | 2024-11-19 18:06:20 |
| BBIO | BridgeBio Pharma, Inc. | KKR Genetic Disorder L.P. | 10% Owner | 2024-09-13 | Sell | 5,800,000 | 25.75 | 149,350,000 | 2024-09-17 18:44:33 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2024-08-16 | Sell | 27,389 | 24.69 | 676,256 | 2024-08-20 18:31:14 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Chief Executive Officer | 2024-08-16 | Option Exercise | 55,537 | 0.00 | 0 | 2024-08-20 18:31:14 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2024-06-03 | Sell | 2,500 | 30.32 | 75,793 | 2024-06-05 16:53:19 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2024-05-16 | Option Exercise | 60,667 | 0.00 | 0 | 2024-05-17 16:11:43 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2024-05-16 | Option Exercise | 27,507 | 0.00 | 0 | 2024-05-17 16:09:25 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2024-03-01 | Sell | 2,500 | 34.00 | 85,000 | 2024-03-05 16:00:11 |
| BBIO | BridgeBio Pharma, Inc. | HOMCY CHARLES J | Directior | 2024-02-16 | Option Exercise | 3,760 | 0.00 | 0 | 2024-02-21 16:04:30 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2024-02-16 | Option Exercise | 102,249 | 0.00 | 0 | 2024-02-21 16:03:37 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2024-02-15 | Sell | 2,915 | 37.75 | 110,041 | 2024-02-20 16:03:00 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2024-02-15 | Option Exercise | 2,915 | 8.45 | 24,632 | 2024-02-20 16:03:00 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2021-12-28 | Buy | 3,433 | 12.96 | 44,476 | 2024-02-13 16:00:10 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2024-01-16 | Sell | 2,915 | 37.97 | 110,683 | 2024-01-18 16:10:54 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2024-01-16 | Option Exercise | 2,915 | 8.45 | 24,632 | 2024-01-18 16:10:54 |
| BBIO | BridgeBio Pharma, Inc. | MCCORMICK FRANK | Directior | 2023-12-26 | Sell | 100,000 | 42.06 | 4,206,000 | 2023-12-28 16:00:11 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2023-12-18 | Sell | 2,000 | 40.00 | 80,000 | 2023-12-20 16:00:06 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2023-12-15 | Sell | 2,915 | 36.12 | 105,290 | 2023-12-19 16:00:06 |
| BBIO | BridgeBio Pharma, Inc. | Valantine Hannah | Directior | 2023-12-15 | Option Exercise | 2,915 | 8.45 | 24,632 | 2023-12-19 16:00:06 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2023-12-01 | Sell | 2,500 | 29.40 | 73,500 | 2023-12-05 16:00:09 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-11-16 | Sell | 22,685 | 29.10 | 660,059 | 2023-11-20 16:00:58 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-11-16 | Option Exercise | 44,996 | 0.00 | 0 | 2023-11-20 16:00:58 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-11-16 | Sell | 51,552 | 29.10 | 1,500,038 | 2023-11-20 16:00:24 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-11-16 | Option Exercise | 102,249 | 0.00 | 0 | 2023-11-20 16:00:24 |
| BBIO | BridgeBio Pharma, Inc. | HOMCY CHARLES J | Directior | 2023-11-16 | Option Exercise | 3,760 | 0.00 | 0 | 2023-11-20 16:00:22 |
| BBIO | BridgeBio Pharma, Inc. | Scott Randal W. | Directior | 2023-09-05 | Sell | 2,500 | 30.00 | 75,000 | 2023-09-07 16:00:09 |
| BBIO | BridgeBio Pharma, Inc. | HOMCY CHARLES J | Directior | 2023-08-16 | Option Exercise | 3,760 | 0.00 | 0 | 2023-08-18 16:00:15 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-08-16 | Sell | 22,683 | 28.59 | 648,455 | 2023-08-18 16:00:10 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-08-16 | Option Exercise | 44,994 | 0.00 | 0 | 2023-08-18 16:00:10 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-08-16 | Sell | 51,552 | 28.59 | 1,473,784 | 2023-08-18 16:00:08 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-08-16 | Option Exercise | 102,250 | 0.00 | 0 | 2023-08-18 16:00:08 |
| BBIO | BridgeBio Pharma, Inc. | VIKING GLOBAL INVESTORS LP | 10% Owner | 2023-07-18 | Sell | 1,500,000 | 35.00 | 52,500,000 | 2023-07-19 21:33:35 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-05-16 | Sell | 51,552 | 14.01 | 722,218 | 2023-05-18 16:07:30 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-05-16 | Option Exercise | 102,249 | 0.00 | 0 | 2023-05-18 16:07:30 |
| BBIO | BridgeBio Pharma, Inc. | HOMCY CHARLES J | Directior | 2023-05-16 | Option Exercise | 3,759 | 0.00 | 0 | 2023-05-18 16:05:30 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-05-16 | Sell | 24,424 | 14.01 | 342,168 | 2023-05-18 16:02:33 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-05-16 | Option Exercise | 44,996 | 0.00 | 0 | 2023-05-18 16:02:33 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-05-03 | Sell | 120,000 | 14.18 | 1,701,744 | 2023-05-05 16:03:40 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-05-03 | Sell | 64,929 | 14.18 | 920,693 | 2023-05-05 16:01:30 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-04-05 | Sell | 55,500 | 15.45 | 857,697 | 2023-04-07 16:42:47 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-04-05 | Sell | 120,000 | 15.46 | 1,855,656 | 2023-04-07 16:39:23 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-03-03 | Sell | 62,692 | 10.96 | 687,148 | 2023-03-03 20:04:01 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-03-03 | Sell | 120,000 | 10.96 | 1,315,224 | 2023-03-03 20:01:48 |
| BBIO | BridgeBio Pharma, Inc. | SCHELLER RICHARD H | Directior | 2023-02-16 | Option Exercise | 3,196 | 0.00 | 0 | 2023-02-21 20:21:54 |
| BBIO | BridgeBio Pharma, Inc. | Cook Jennifer E. | Directior | 2021-11-16 | Option Exercise | 3,576 | 0.00 | 0 | 2023-02-21 20:19:37 |
| BBIO | BridgeBio Pharma, Inc. | HOMCY CHARLES J | Directior | 2023-02-16 | Option Exercise | 3,760 | 0.00 | 0 | 2023-02-21 20:18:09 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-02-16 | Sell | 17,717 | 12.70 | 225,066 | 2023-02-21 20:16:34 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-02-16 | Option Exercise | 27,627 | 0.00 | 0 | 2023-02-21 20:16:34 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-02-16 | Sell | 44,798 | 12.70 | 569,074 | 2023-02-21 20:12:31 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-02-16 | Option Exercise | 68,706 | 0.00 | 0 | 2023-02-21 20:12:31 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-02-03 | Sell | 61,040 | 11.01 | 671,922 | 2023-02-06 19:43:51 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-02-03 | Sell | 120,000 | 11.01 | 1,320,696 | 2023-02-06 19:26:10 |
| BBIO | BridgeBio Pharma, Inc. | STEPHENSON BRIAN C | Secretary, Treasurer & CFO | 2023-01-05 | Sell | 61,040 | 7.67 | 468,470 | 2023-01-06 20:38:34 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2023-01-05 | Sell | 120,000 | 7.67 | 920,856 | 2023-01-06 20:35:53 |
| BBIO | BridgeBio Pharma, Inc. | Kumar Neil | CEO and President | 2022-12-21 | Sell | 200,000 | 0.00 | 0 | 2022-12-21 19:58:53 |
